Use the link below to read or download ATXA Therapeutics published article on the expression and regulation of thromboxane receptors in chronic inflammation within the prostate. No sign up, registration or fees are required before September 06, 2019. https://authors.elsevier.com/a/1ZPfg3IjaQ2TM
ATXA Therapeutics, along with members of the academic research group of CSO Prof. Therese Kinsella at University College Dublin, have published a new paper on the expression and regulation of thromboxane receptors in chronic inflammation within the prostate. The manuscript, entitled Differential expression of the TPα and TPβ isoforms of the human T Prostanoid Receptor during chronic inflammation of the Prostate: Role for FOXP1 in the transcriptional regulation of TPβ during monocyte-macrophage differentiation, was recently accepted for publication in Experimental and Molecular Pathology. While a role for thromboxane signalling in the modulation of immunity has been established, the precise r
